Generation, purification and transplantation of photoreceptors derived from human induced pluripotent stem cells.

Lamba DA, McUsic A, Hirata RK, Wang PR, Russell D, Reh TA. · 2010

Read Generation, purification and transplantation of photoreceptors derived from human induced pluripotent stem cells. by Lamba DA, McUsic A, Hirata RK, Wang PR, Russell D, Reh TA. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc2808350.txt.

Introduction

Lamba, McUsic, Hirata, Wang, Russell, and Reh grew light-sensing eye cells in 2010 from human induced pluripotent stem cells, which are adult cells rewound to a stem-like state. Retinal diseases that kill these cells, called photoreceptors, rank among the main causes of blindness, and replacement cells could one day restore sight.

Starting from skin cells, the team steered the rewound cells toward a retinal fate using their earlier recipe for embryonic stem cells. A glowing tag lit up true photoreceptors, letting the team sort out a pure batch. Planted into a normal mouse retina, the sorted cells settled into the tissue and switched on photoreceptor proteins, a step toward patient-matched transplants.

Catalog record

CREATORLamba DA, McUsic A, Hirata RK, Wang PR, Russell D, Reh TA.
YEAR2010
COLLECTIONPAPERS
FORMATTXT
FILE SIZE42 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC2808350

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Generation, Purification and Transplantation of Photoreceptors Derived from Human Induced Pluripotent Stem Cells By Deepak A Lamba, Andrew McUsic, Roli K Hirata, Pei-Rong Wang, David Russell, Thomas A Reh, Rafael Linden Published in: PLoS ONE DOI: 10.1371/journal.pone.0008763 ABSTRACT Abstract Background Inherited and acquired retinal degenerations are frequent causes of visual impairment and photoreceptor cell replacement therapy may restore visual function to these individuals. To provide a source of new retinal neurons for cell based therapies, we developed methods to derive retinal progenitors from human ES cells. Methodology/Physical Findings In this report we have used a similar method to direct induced pluripotent stem cells (iPS) from human fibroblasts to a retinal progenitor fate, competent to generate photoreceptors. We also found we could purify the photoreceptors derived from the iPS cells using fluorescence activated cell sorting (FACS) after labeling photoreceptors with a lentivirus driving GFP from the IRBP cis-regulatory sequences. Moreover, we found that when we transplanted the FACS purified iPSC derived photoreceptors, they were able to integrate into a normal mouse retina and express photoreceptor markers. Conclusions This report provides evidence that enriched populations of human photoreceptors can be derived from iPS cells. INTRODUCTION Retinal degenerations that involve rod and cone photoreceptors are a major cause of blindness, and affect millions of people in the US. These devastating conditions can be inherited or acquired, and while efforts are underway to develop treatments that slow or prevent these conditions using gene therapy or medical treatments, once the photoreceptors have degenerated, cell replacement or prosthetic devices are the only options. Cell replacement of photoreceptors has been shown to be feasible, even in mature mice, where photoreceptors transplanted to the sub-retinal space can integrate into the retina and function [1], [2]. We, and others, have developed protocols for generating retinal progenitors and photoreceptors from human embryonic stem cells as a potential source of replacement photoreceptors for cell-based therapy of retinal degenerations [3], [4], [5]. Our protocol involves the directed differentiation of undifferentiated human embryonic stem (hES) cells into retinal progenitor cells, followed by expansion of these cells and their differentiation into photoreceptors. These cells can be transplanted to the sub-retinal space of visually deficient mice and can restore some light response [2]. One of the problems with cell-based therapies is that recipients may require immuno-suppressant drugs to prevent rejection of the transplanted cells. One way around this complication is to use cells derived from closely related or HLA-matched individuals or even the patients themselves, using induced pluripotent stem cells (iPS). iPS cells were initially generated by Shinya Yamanaka and colleagues by expressing combinations of candidate genes into mouse embryonic fibroblasts [6]. The four genes that were required, OCT3/4, SOX2, KLF4 and c-MYC have also been shown to induce pluripotency in human fibroblasts, and various combinations of these and small molecules can efficiently induce the pluripotent state in a variety of different cell types [6], [7], [8], [9], [10], [11]. The iPS cells behave similarly to ES cells in most assays, including contributing to mouse germline transmission [9]. Several groups have shown that iPS cells can be directed to a variety of lineages and may be useful for studying specific diseases where animal models do not exist or are inadequate (eg. [12]). The similarity of iPS cells to hES cells led us to ask whether these cells would respond to our retinal determination protocol like the ES cells. In this report we show that iPS cells, generated with the combination of OCT4, SOX2, NANOG and LIN28, can be directed to a retinal progenitor fate using the same protocol as we developed for hES cells. Moreover, we show for the first time that iPSC-derived photoreceptors can be identified in the cultures by infection with a viral construct in which GFP is driven from a photoreceptor-specific (IRBP) promoter. The GFP+ photoreceptors can be highly purified using FACS, providing a potentially unlimited source for cell-based therapies of retinal degenerations. Lastly, we show that the iPSC-derived photoreceptors that have been purified by FACS integrate into the outer nuclear layer after transplantation to the sub-retinal space of adult mice, similar to normal mouse photoreceptors and ES cell derived rod photoreceptors. The ability to derive retinal photoreceptors from iPS cells will also be useful in the development of in vitro models of specific human retinal degenerations. MATERIALS AND METHODS Cell Culture and Retinal Induction H-1 (WA01) line was obtained from Wicell, the Hues6, Hues14 and Hues16 were obtained from Doug Melton (Harvard University, MA) and Mel1 and Mel2 lines were purchased from Millipore. An iPS cell line was made by infecting a human fibroblast culture (Coriell GM05387) with lentiviral vectors expressing OCT4, NANOG, LIN28 and SOX2 as described [11]. All cell lines were initially maintained with CF-1 feeders and subsequently adapted to feeder-free conditions. Retinal induction was performed by modifying the protocol previously described [5]. Instead of making embryoid bodies, 25–30 of the 150–200 ES cell clumps were plated on Matrigel coated 35mm dishes and cultured for 3 days in the presence of mouse noggin (1 ng/ml, R&D Systems), human recombinant Dkk-1 (1 ng/ml, R&D Systems) and human recombinant insulin-like growth factor-1 (IGF-1) (1 ng/ml, R&D Systems). From the fourth day, the concentration of the factors was increased to 10 ng/ml. The media was changed every 2–3 days for up to three weeks. The cells were cultured for several months in media containing N2 and B27 supplement without any additional factors for further differentiation. Immunocytochemistry and Immunohistochemistry Cells and eyes were fixed with 4% paraformaldehyde and analyzed with the following antibodies using protocol previously described: rabbit anti-recoverin (gift from Dr. Jim Hurley, University of Washington, 1∶1000), mouse anti-Hu C/D (Molecular Probes, 1∶200), mouse anti-rhodopsin (Rho-4D2) (gift from Dr. Molday, University of British Columbia, 1∶750), mouse anti-Pax6 (1∶250) and mouse anti-SSEA4 (1∶10) (DHSB), mouse anti-human α-SMA, mouse anti-human AFP and mouse anti-MAP2 (Millipore), chicken anti-GFP (1∶500) and rabbit anti-Sox9 (1∶400) (Abcam), rabbit anti-S-opsin (gift from Dr. J Nathans, Johns Hopkins University, 1∶1000), rabbit anti-Nrl (gift from Dr. A. Swaroop, 1∶500), goat anti-Otx2-biotin (R&D Systems, 1∶250), rabbit anti-AIPL1 (gift from Dr. V. Ramamurthy, 1∶5000), rabbit anti-Crx (gift from Dr. C. Craft, 1∶250), rabbit anti-ZO-1 (Invitrogen, 1∶250), goat anti-Sox2 (1∶500), goat anti-Oct3/4 (1∶250), goat anti-Brn3 (1∶100) and rat anti-Blimp1 (1∶100) (Santa Cruz). Secondary antibody staining was done using the corresponding Cy5 (Jackson Immunoresearch), Cy5-conjugated streptavidin, Alexa-488, Alexa-568, and Alexa 633 fluorescent-conjugated antibodies (Invitrogen, 1∶500). The primary antibodies were used at the appropriate dilution in 0.5% Triton X-100 and 5% dry milk in PBS overnight at 4°C. The slides were then washed 3 times in PBS followed by 1 hour in secondary antibody at room temperature. Images were taken using a Nikon A1 confocal microscope. Image analysis was performed using Volocity software (Improvision) and Adobe Photoshop CS4. All counts shown as mean +/− SEM. Virus Production and Infection EF-1a-GFP lentivirus was made using constructs provided by Dr. Charles Murry (University of Washington). The IRBP-GFP lentivirus was prepared using the human IRBP promoter from Dr. Paul Overbeek (Baylor College of Medicine, TX). pRRL-cPPT-CMV lentivirus plasmid was cut to remove the CMV promoter and replaced with the multiple cloning site and the eGFP portion from pEGFP1 plasmid (Clonetech). The human IRBP promoter was next subcloned into the

Read the complete text